- Home
- BROS vs CORT Comparison
BROS vs CORT Comparison
Compare BROS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BROS | CORT |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BROS | CORT |
|---|---|---|
| Price | $64.75 | $83.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 6 |
| Target Price | $77.16 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 3.2M | 965.7K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.73 | N/A |
| EPS | 0.51 | ★ 0.87 |
| Revenue | ★ $1,537,335,000.00 | $741,172,000.00 |
| Revenue This Year | $28.73 | $23.79 |
| Revenue Next Year | $25.41 | $40.97 |
| P/E Ratio | $128.14 | ★ $95.90 |
| Revenue Growth | ★ 28.93 | 17.92 |
| 52 Week Low | $47.16 | $49.00 |
| 52 Week High | $86.88 | $117.33 |
Technical Indicators
Market Signals| Indicator | BROS | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 68.89 | 56.52 |
| Support Level | $60.25 | $78.07 |
| Resistance Level | $65.93 | $89.00 |
| Average True Range (ATR) | 1.94 | 3.58 |
| MACD | 0.53 | -0.28 |
| Stochastic Oscillator | 88.64 | 59.52 |
Price Performance
Historical ComparisonAbout BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.